Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis

Fig. 2

Combination therapy with BUD and NAC improves the neutrophil-induced inflammatory response. A Flow cytometry for surface expression of CD35 and CD62 L; B Neutrophil extracellular trap network formation assay; C-F ELISA for cytokine expression; G-J. RT–qPCR for cytokine mRNA expression. Compared with the NC group, ** P < 0.01, *** P < 0.001; compared with the LPS group, # P < 0.05, ## P < 0.01, ### P < 0.001; compared with the LPS + BUD group, $ P < 0.05, $$ P < 0.01, $$$ P < 0.001; compared with the LPS + NAC group, & P < 0.05, && P < 0.01, &&& P < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us